Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases

US7045544B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Jens-Kerim Ergüden · Uerdingen, DE
• Thomas Krahn · Hagen, DE
• Christian Schroder · Bergheim, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Stefan Weigand · Wuppertal, DE
• Hanno Wild · Wuppertal, DE
• Michael Brands · Hamden, US

Key dates

• Filing date: Sep 16, 2002
• Grant date: May 16, 2006
• Expiry date: Sep 16, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D209/42
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compounds of formula (I), to a method for the production thereof, and to the use of the same as pharmaceuticals for the treatment of diseases in humans and/or animals